Pharmaceutical Sciences Graduate Major (MS, PhD)
This program is available at the following locations:
- Corvallis (MS Non-Thesis, MS Thesis, PhD)
- Ecampus (MS Non-Thesis)
The MS degree in Pharmaceutical Sciences is designed to prepare students for careers or advancement in the pharmaceutical and biotechnology industries or regulatory careers. The PhD degree in Pharmaceutical Sciences is designed to prepare students to lead research programs in academia, regulatory, pharmaceutical and/or biomedical industry to discover, develop and deliver new drug treatments to promote health. The non-thesis MS degree is offered both on-campus and through Ecampus. Thesis MS and PhD degree programs are offered on-campus only. Faculty in the graduate programs in Pharmaceutical Sciences are involved in research that aims to identify novel chemicals and characterize the therapeutic potential of new agents from diverse biological sources; design and develop nanoparticles for targeted drug delivery; discover and investigate new drug targets to treat human diseases; explore the impact of the human microbiome on health and disease and advance all these research programs with new computational approaches.
Major Code: 4790
Upon successful completion of the program, students will meet the following learning outcomes:
MS Non-Thesis
- Conduct research or produce some other form of creative work.
- Demonstrate mastery of subject material.
- Conduct scholarly or professional activities in an ethical manner.
- Design logical and realistic solutions to problems in pharmaceutical sciences by using critical thinking and analytical skills.
- Effectively analyze, summarize, evaluate and discuss the primary research literature.
MS Thesis
- Conduct research or produce some other form of creative work.
- Demonstrate mastery of subject material.
- Conduct scholarly or professional activities in an ethical manner.
- Design logical and realistic solutions to problems in pharmaceutical sciences by using critical thinking and analytical skills.
- Effectively communicate research findings and significance including impact on human health.
PhD
- Produce and defend an original significant contribution to knowledge.
- Demonstrate mastery of subject material.
- Conduct scholarly activities in an ethical manner.
- Design logical and realistic solutions to problems in pharmaceutical sciences by using critical thinking and analytical skills.
- Effectively design an experimental approach and conduct research to advance knowledge in pharmaceutical sciences.
- Effectively communicate research findings including impact on human health.
MS Non-Thesis
| Code | Title | Credits |
|---|---|---|
| PHAR 522 | DRUGS AND THE BODY | 3 |
| or PHAR 735 | DRUG ACTION I: MEDICINAL CHEMISTRY AND PHARMACEUTICS | |
| GRAD 520 | RESPONSIBLE CONDUCT OF RESEARCH | 2 |
| PHAR 507 | SEMINAR | 1 |
| PHAR 506 | PROJECTS | 3 |
| Electives 1,2 | 36 | |
| Total Credits | 45 | |
- 1
BB 550 and BB 551 are strongly recommended unless an upper-level biochemistry sequence was satisfactorily completed elsewhere or prior to admission
- 2
Elective coursework shall be chosen by the student in consultation with their major advisor from graduate-level courses available in the College of Pharmacy or other related units. At least 28 didactic credits must be completed in addition to the required didactic courses. The remaining elective credits may be a combination of didactic courses, PHAR 507, PHAR 501 and/or PHAR 506 within limits established for masters degrees
MS Thesis
| Code | Title | Credits |
|---|---|---|
| PHAR 522 | DRUGS AND THE BODY | 3 |
| or PHAR 735 | DRUG ACTION I: MEDICINAL CHEMISTRY AND PHARMACEUTICS | |
| GRAD 520 | RESPONSIBLE CONDUCT OF RESEARCH | 2 |
| PHAR 507 | SEMINAR (1 credit required; recommended every term) | 1 |
| PHAR 503 | THESIS | 6 |
| Electives 1,2 | 33 | |
| Total Credits | 45 | |
- 1
BB 550 and BB 551 are strongly recommended unless an upper-level biochemistry sequence was satisfactorily completed elsewhere or prior to admission
- 2
Elective coursework shall be chosen by the student in consultation with their major advisor from graduate-level courses available in the College of Pharmacy or other related units. At least 28 didactic credits must be completed in addition to the required didactic courses. The remaining elective credits may be a combination of didactic courses, PHAR 507, PHAR 501 and/or PHAR 503 within limits established for masters degrees
PhD
| Code | Title | Credits |
|---|---|---|
| PHAR 522 | DRUGS AND THE BODY | 3 |
| or PHAR 735 | DRUG ACTION I: MEDICINAL CHEMISTRY AND PHARMACEUTICS | |
| GRAD 520 | RESPONSIBLE CONDUCT OF RESEARCH 1 | 2 |
| PHAR 507 | SEMINAR (1 credit required; recommended every term) | 1 |
| PHAR 669 | INTRODUCTION TO GRANT PROPOSAL WRITING | 2 |
| PHAR 603 | THESIS (repeatable) | 36 |
| Electives 2,3 | 64 | |
| Total Credits | 108 | |
- 1
May substitute equivalent training in ethical conduct of research
- 2
Either BB 550 and BB 551 or BB 590, BB 591 and BB 592 are strongly recommended unless an upper-level biochemistry sequence was satisfactorily completed elsewhere or prior to admission
- 3
The remaining coursework shall be chosen by the student in consultation with their major advisor from didactic graduate-level courses available in the College of Pharmacy or other related unit. At least 20 didactic credits must be completed in addition to the required didactic courses. The remaining elective credits may be a combination of didactic courses, PHAR 507, PHAR 601 and/or PHAR 603 within limits established for PhD degrees